We are an international team of scientists, clinicians, and entrepreneurs who share a goal of creating advanced gene therapies that are safe, effective, scalable, and equal opportunity.
Together, we have built NV Therapeutics with the confidence that a new generation of therapies can be non-viral.
NV Therapeutics Leadership
-
Kevin Holden, Ph.D.
CEO & CO-FOUNDER
-
Jake Lamson, M.S.
DIRECTOR OF SYNTHETIC BIOLOGY
& CO-FOUNDER -
Eduardo Seclén, Ph.D.
DIRECTOR OF GENE EDITING
Founding Scientists & Clinicians
-
Adrian Thrasher, M.D., Ph.D.
SCIENTIFIC CO-FOUNDER
& ADVISOR -
Donald Kohn, M.D.
SCIENTIFIC CO-FOUNDER
& ADVISOR -
Giorgia Santilli, Ph.D.
SCIENTIFIC CO-FOUNDER
& ADVISOR -
Daniel Dever, Ph.D.
SCIENTIFIC CO-FOUNDER
ADVISOR & BOARD MEMBER
Investors & Board Members
-
Dima Kuzmin, Ph.D.
BOARD DIRECTOR
& SCIENTIFIC CO-FOUNDER -
Andrew Kozlov, MBA
BOARD MEMBER